Nanodrug modified with engineered cell membrane targets CDKs to activate aPD-L1 immunotherapy against liver metastasis of immune-desert colon cancer
Dongbing Ding, Rongpu Liang, Tan Li, Tianyun Lan, Yiquan Li, Shengxin Huang, Guanhui He, Jiannan Ren, Weibo Li, Zongheng Zheng, Tufeng Chen, Jiafeng Fang, Lijun Huang, Xintao Shuai, Bo Wei
Topics & Concepts
MetastasisImmunotherapyCancer researchImmune systemCyclin-dependent kinaseColorectal cancerMedicineCancerImmunologyInternal medicineCell cycleCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCancer Cells and Metastasis